Evidence map›Paper›PMID 14742723›Full record

ArticleThe Journal of physiology2004

Serotonergic facilitation of synaptic activity in the developing rat prefrontal cortex.

Jean-Claude Béïque, Esther M Chapin-Penick, Ljiljana Mladenovic, Rodrigo Andrade

Open access · greenAbstract read
In one paragraph

Article in The Journal of physiology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Heterodimers of serotonin receptor subtypes 2 are driven by 5-HTThe Journal of biological chemistry · 2017
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Serotonin pharmacology in the gastrointestinal tract: a review.Naunyn-Schmiedeberg's archives of pharmacology · 2008
    Review
  16. The behavioral pharmacology of hallucinogens.Biochemical pharmacology · 2008
    Review
  17. Review
  18. Mechanism of the 5-hydroxytryptamine 2A receptor-mediated facilitation of synaptic activity in prefrontal cortex.Proceedings of the National Academy of Sciences of the United States of America · 2007
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Jean-Claude BéïqueDepartment of Psychiatry and Behavioural Neurosciences, Wayne State University School of Medicine, 540 E. Canfield, Rm 2309 Scott Hall, Detroit, MI 48201, USA. jbeique@med.wayne.edu
Esther M Chapin-Penick
Ljiljana Mladenovic
Rodrigo Andrade
Wayne State University · USBrown University · US

Funding

MECHANISMS AND REGULATION OF 5HT RECEPTORS IN THE CNSR01MH043985 · NIMH · WAYNE STATE UNIVERSITY · PI ANDRADE, RODRIGO · 1993 to 2017
$5.7M
MECHANISMS AND REGULATION OF 5-HT RECEPTORS IN THE CNSR29MH043985 · NIMH · SAINT LOUIS UNIVERSITY · PI ANDRADE, RODRIGO · 1988 to 1992
–
NIMH NIH HHS MH43985NIMH NIH HHS R01 MH043985NIMH NIH HHS R29 MH043985
6 · The paper itself

Abstract

Previous studies have outlined an important role for serotonin (5-HT) in the development of synaptic connectivity and function in the cerebral cortex. In this study, we have examined the effects of 5-HT on synaptic function in prefrontal cortex at a time of intense synapse formation and remodelling. Whole-cell recordings in slices derived from animals aged postnatal (P) days 16-20 showed that administration of 5-HT induced a robust increase in synaptic activity that was blocked by CNQX but not by bicuculline. This 5-HT-induced increase in glutamate-mediated synaptic activity was pharmacologically heterogeneous as it was differentially inhibited by the receptor subtype-selective antagonists SB-269970, MDL 100907 and GR 113808 and thus involved 5-HT(7), 5-HT(2A) and 5-HT(4) receptors. These results, obtained in juvenile cortex, contrast with those seen in adults where the increase in spontaneous excitatory postsynaptic currents (sEPSCs) was mediated solely by 5-HT(2A) receptors. In developing cortex, activation of 5-HT(7), but not 5-HT(2A) or 5-HT(4) receptors, elicited a robust inward current. However, the facilitation of synaptic activity mediated by all three of these receptors involved increases in both the amplitude and frequency of sEPSCs and was blocked by TTX. These results are best interpreted as indicating that all three receptor subtypes increase synaptic activity by exciting neuronal elements within the slice. No evidence was found for a postsynaptic facilitation of synaptic currents by 5-HT. Together, these results show that the repertoire of electrophysiologically active 5-HT receptors in prefrontal cortex is developmentally regulated, and that 5-HT(7) and 5-HT(4) receptors play a previously unsuspected role in regulating synaptic activity in this region.

Indexed as

6-Cyano-7-nitroquinoxaline-2,3-dioneAmphetaminesAnimalsBicucullineFluorobenzenesGABA-A Receptor AntagonistsGlutamic AcidIndolesLidocaineMalePatch-Clamp TechniquesPhenolsPindololPiperidinesPrefrontal CortexPyramidal Cells4-iodo-2,5-dimethoxyphenylisopropylamine6-Cyano-7-nitroquinoxaline-2,3-dioneAmphetaminesBicucullinecyanopindololFluorobenzenesGABA-A Receptor AntagonistsGlutamic AcidGR 113808IndolesLidocainePhenolsPindololPiperidinesQX-314Receptors, AMPAReceptor, Serotonin, 5-HT2AReceptors, Metabotropic GlutamateReceptors, SerotoninReceptors, Serotonin, 5-HT4SB 269970SerotoninSerotonin 5-HT1 Receptor AntagonistsSerotonin 5-HT2 Receptor AntagonistsSerotonin 5-HT4 Receptor Antagonistsserotonin 7 receptorSerotonin AntagonistsSodium Channel BlockersSulfonamidesTetrodotoxinvolinanserin

Identifiers

PMID14742723
PMCPMC1665004
OpenAlexW2159001308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.